Living Proof (2008) Timeline Explained – Every Event in Order

The drug company temporarily halted funding during the Herceptin research phase, creating a critical funding crisis. The exact reasons are tied to corporate decision-making around risk and investment priorities for experimental therapies. This withdrawal threatened to end the project entirely until philanthropists stepped in to fill the financial gap.

Foreshadowing: The funding crisis is hinted at early in the film when Slamon faces corporate skepticism about the unproven treatment approach.

• funding crisis
• drug company
• Herceptin
• research halt
• pharmaceutical

When the drug company withdrew funding, philanthropists Lilly Tartikoff and Ronald Perelman became crucial backers. Tartikoff organized the Fire and Ice Ball fundraiser to raise money, while Perelman donated through his Revlon charity. These contributions provided the critical capital that kept the research alive and allowed clinical trials to continue.

Foreshadowing: The film establishes early that scientific breakthroughs often depend on financial support beyond corporate funding.

• philanthropy
• Lilly Tartikoff
• Ronald Perelman
• Fire and Ice Ball
• funding
• Herceptin

Nicole, the first patient to receive Herceptin, was excluded from later clinical trials because she did not meet the trial's specific eligibility criteria. Despite her mother Elizabeth pleading with Dr. Slamon, the strict study design required consistent patient parameters. Her compassionate use case demonstrated the drug's potential but could not be included in the controlled trial data.

Foreshadowing: Nicole's initial treatment earlier in the film sets up the tension between compassionate use and rigorous trial requirements.

• Nicole
• clinical trials
• eligibility
• excluded
• Herceptin
• treatment criteria

Herceptin was a targeted therapy that blocked the HER2 receptor, unlike chemotherapy which attacks all rapidly dividing cells. This approach offered hope for breast cancer patients without the harsh side effects of radiation or traditional chemotherapy. Dr. Slamon believed it could transform patient outcomes by specifically targeting HER2-positive cancers.

Foreshadowing: The film's emphasis on HER2 as a specific target foreshadows the drug's innovative mechanism.

• Herceptin
• targeted therapy
• HER2
• chemotherapy
• breast cancer treatment
• mechanism

HER2 is a protein that promotes cancer cell growth. Herceptin works by blocking the HER2 receptor, essentially starving the cancer cells of the signals they need to multiply. The drug specifically targets patients whose breast cancer tests positive for excess HER2 proteins, making it one of the first personalized cancer treatments.

Foreshadowing: The film's focus on HER2 testing establishes why patient selection matters for the drug's effectiveness.

• HER2
• protein
• receptor
• targeted therapy
• breast cancer
• Herceptin mechanism

The Fire and Ice Ball, organized by Lilly Tartikoff, was a major fundraiser that mobilized celebrities and donors to support Herceptin research. The event provided crucial funding and public awareness, helping sustain the trials during the period when corporate backing had been withdrawn. It represented the public support behind the scientific effort.

Foreshadowing: Tartikoff's commitment to helping cancer patients is established early when she becomes involved with the project.

• Fire and Ice Ball
• fundraiser
• Lilly Tartikoff
• celebrity
• donations
• research funding

The women participating in the Herceptin trials formed a resilient supportive community. They shared their experiences, fears, and hopes throughout the process. Tish used humor to lighten the mood and cope with the disease, while others like Tina explored alternative therapies alongside the trial. Their camaraderie reinforced the human stakes behind the scientific work.

Foreshadowing: The film begins showing the women's interactions early, establishing their bonds before the trials intensify.

• patients
• support community
• trials
• Tish
• Tina
• camaraderie
• breast cancer

Dr. Slamon believed strongly in the scientific potential of targeting HER2 receptors to treat breast cancer. As a physician-scientist at UCLA, he saw the possibility of transforming patient outcomes with a treatment that could work without traditional chemotherapy's devastating side effects. His determination came from both scientific conviction and witness to his patients' struggles.

Foreshadowing: The opening scenes establish Slamon's scientific drive and his connection to patient welfare.

• Dennis Slamon
• determination
• scientist
• skepticism
• HER2
• motivation
• UCLA

The Herceptin trials faced multiple challenges including funding gaps when the drug company withdrew support, strict eligibility criteria that excluded some hopeful patients like Nicole, and the inherent risks of testing a new therapy on seriously ill patients. Some participants died during the trials while others recovered, highlighting the uncertainties of early cancer research.

Foreshadowing: The timeline shows funding problems starting in 1990, creating early obstacles.

• clinical trials
• challenges
• funding
• eligibility
• patient deaths
• risks
• Herceptin

FDA approval of Herceptin in 1996 marked a turning point in breast cancer care. It became the first targeted therapy specifically for HER2-positive breast cancer, offering patients a treatment option that was more targeted and potentially less harsh than chemotherapy. The drug fundamentally reshaped approaches to cancer treatment and gave new hope to patients with this specific cancer type.

Foreshadowing: The film's hopeful tone and Dr. Slamon's persistence foreshadow the eventual breakthrough.

• FDA approval
• Herceptin
• breakthrough
• breast cancer treatment
• HER2-positive
• transformation